Home
Parallel Trade
14 February - 15 February 2007
Parallel Trade

With evidence suggesting that there are no direct benefits to patients through the application of parallel trade, is it time that policymakers re-evaluated current practices to protect the pharmaceutical industry? SAE Media Group’s conference ‘Parallel Trade’ will seek to uncover the true impact on drug manufacturers, patients and research and development. Discussing safety, regulatory policy, intellectual property and packaging, hear key leaders in the field provide advice on how to strategically combat this growing problem. Through case studies and plenary lectures, listen to aspects of parallel trade with a focus on pricing & reimbursement and wholesale & distribution.

Hear cutting edge contributions from leaders in the field, including:

  • Dr Thomas Zimmer, Corporate Senior Vice President, CD Safety, Quality and Environmental Protection, Boehringer-Ingelheim
  • Neil Palmer, Vice President, Pricing and Reimbursement, RTI Health Solutions
  • Kipp Snider, Director, State Government Affairs, Global Government Affairs, Amgen
  • Eric Noehrenberg, Director, International Trade and Market Policy, International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
  • Stefan Rinn, Head, Corporate Division, Prescriptions Medicines, Europe, Boehringer-Ingelheim
  • Huda Midani, Vice President, Business Development, Healthcare & Life Sciences, Authentix
  • Bruce Dudzik, Senior Director, Business Development, NanoInk
  • Donald Macarthur, Senior Consultant, PriceSpective & Former Secretary General, European Association of Euro-Pharmaceutical Companies
  • Boris Simovich, President, Light Management Consulting

Key issues that will be addressed at the conference include:

  • The Effect of Parallel Trade: Hear global perspectives about the economic and socialistic impacts of parallel trade on patients, pharmaceutical manufacturers and traders in the EU and US
  • Pricing and Reimbursement: Learn about the true impact of parallel trade and discover if the concept of a single market can ever be a reality
  • Wholesale and Distribution: Hear how parallel trade has and will affect cross border trade and the pharmaceutical supply chain and practical considerations to overcome it
  • Regulatory Affairs and Intellectual Property: Discuss effective strategies to overcome the challenges facing the industry and gain the knowledge of how to ensure product compliance
  • Pharmaceutical Packaging and Tracking: Strategies and tactics to ensure product safety, brand integrity and consumer confidence
  • Networking Opportunities: Meet the key leaders in the field, make valuable contacts and learn from their experience and expertise

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Welcome and introductions

clock

9:10

How should a parallel trader choose which country to target?

·               Size?
·               Barriers?
·               Incentives?

clock

10:00

What product features most attract a parallel trader?

·               Absolute price differentials?
·               Percentage price differentials?
·               Sales volumes?
·               Other features?

clock

10:50

Morning Coffee

clock

11:10

Discussions and questions – review of session

clock

11:20

How does a parallel trader choose where to trade when supplies are limited?

·               Purely on price differentials?
·               Protecting established customers?
·               Other considerations?

clock

12:30

Close of Executive Briefing

clock

13:30

Registration & Coffee

clock

14:00

Welcome and introductions

clock

14:10

Background Facts

·          Scale of issue and its evolution
·          Where is it found? Who are the main players?
·          Trade flow patterns
·          Which products are most and least affected, and why?
·          Key role of the distribution chain
·          Who benefits, who loses, and by how much?

clock

14:10

The parallel trade legal framework

·          An overview of the current regulations governing parallel trade
·          The effect on the pharmaceutical manufacturers
·          Medicare Part D

clock

15:00

Legal Basis

·          EU doctrine of free movement and exhaustion of rights
·          National and EU regulatory approval procedures for parallel trade
·          Key ECJ cases/commission communications
·          Repackaging rules
·          Enlargement's 'specific mechanism'
·          National drivers and constraints to use

clock

15:00

Monitoring cross border trade activities

·          The difficulties associated with logistical evaluation
·          Analysis of European and US operations
·          Overcoming the issues
-                Re-engineering the supply chain process
-                Considering regional distributions
-                Improving customer services

clock

15:50

Afternoon Tea

clock

16:20

Strategic Responses

·          Ensuring regulatory demands are met
·          Enforcing trademark rights
·          Pricing strategies
·          Designing and implementing supply allocation systems
·          Using the specific mechanism

clock

16:20

The risks and how to mitigate

·          Overcoming the regulatory pitfalls
·          The negative, and positive, effects of cross border trade
·          Future steps and practices for pharmaceutical manufacturers

clock

17:10

Discussion and questions

clock

17:30

Close of Executive Briefing

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Boris Simkovich

Boris Simkovich, President, Light Management Consulting LLC

clock

9:10

KEYNOTE ADDRESS

Boris Simkovich

Boris Simkovich, President, Light Management Consulting LLC

·                How has industry’s strategy vis-à-vis parallel trade evolved over time?
·                What strategies have fallen in – and out – of favour?
·                What forces have influenced the evolution of industry strategy?
·                What is the outlook for the future?
clock

9:50

PARALLEL TRADE: DEBUNKING SOME COMMON MYTHS

Donald Macarthur

Donald Macarthur, Senior Consultant, PriceSpective

·                The EU gives the trade unqualified support
·                It's best left to our legal department to manage
·                Pharmacists dispense parallel trade at every opportunity
·                Now the "common origin" criterion for regulatory approval is gone our brands will have to compete with parallel-imported generics
·                Every time the EU enlarges the situation gets worse
·                High prices mean parallel importation into the US is inevitable
clock

10:30

Morning Coffee

clock

11:00

HOW PREDICTABLE IS PARALLEL TRADE?

Gary Johnson

Gary Johnson, Managing Director, Inpharmation Ltd

·                What do people think are the key drivers of parallel trade?
·                What are the actual key drivers?
·                What is system dynamics and why is it the preferred route for PI forecasting?
·                How can you validate a PI forecasting methodology when you cannot observe all the flows?
clock

11:40

DOES PARALLEL TRADE BENEFIT THE PATIENT?

Eric Noehrenberg

Eric Noehrenberg, Director, International Trade and Market Policy, International Federation Of Pharmaceutical Manufacturers Association (I F P M A)

·                Does parallel trade benefit the poor?
·                Parallel trade and counterfeit products
·                Product diversion and access programmes
clock

12:20

Networking Lunch

clock

13:50

PARALLEL TRADE

Stefan Rinn

Stefan Rinn, Head, Corporate Division, Prescription Medicines Europe, Boehringer Ingelheim GmbH

·                Losses of margins
·                Trends in distribution models
·                Legal measures to deal with parallel trade issues
clock

14:30

PHARMACEUTICAL PACKAGING AND TRACKING

Andre Grigjanis

Andre Grigjanis, Managing Director, GCC Pharma

·                Repackaging issues
-       Issues in counterfeiting
-          Affect on safety and quality
-          Tagging (RFID/2D Barcode)
-       Considering standards
·                The importance of drug tracking throughout the pharma supply chain
·                Existing and planned pharma tracking regulations
·                Retaining brand integrity and consumer confidence through packaging
·                Overcoming pitfalls - from consumer clarity to label compliance
clock

15:10

Afternoon Tea

clock

15:40

DRUG TRACKING

Huda Midani

Huda Midani, Vice President, Business Development, Authentix

·                The FDA guidance issued on June 9th 2006
·                The benefits of tracking drugs on patient safety
·                Is there a role for drug tracking in a parallel trade environment?
·                Present and future drug tracking solutions
·                How does drug tracking secure brand integrity to regain consumers' confidence with the healthcare industry?
clock

16:20

REGULATORY ISSUES AND INTELLECTUAL PROPERTY RIGHTS

·                How the European courts are shaping the law on parallel trade

·                Gaining and withdrawing market authorisations

·                Eurogenerics - is there still a difference between generics and parallel imports?

·                Invoking trade mark rights - the state of play

·                Invoking patent rights - the exhaustion of rights rules and the Accession Treaty

·                Withdrawal of reference products and competition law - is the EU importing US rules?

Maarten Meulenbelt

Maarten Meulenbelt, Partner, NautaDutilh

Maarten Meulenbelt

Maarten Meulenbelt, Partner, Howrey LLP

clock

17:00

Chairman’s Closing Remarks and Close of Day One

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Thomas Zimmer

Thomas Zimmer, Corporate Senior Vice President, CD Safety, Quality & Environmental Protection, Boehringer-Ingelheim

clock

9:10

PARALLEL TRADE AND SUPPLY CHAIN TRANSPARENCY

Thomas Zimmer

Thomas Zimmer, Corporate Senior Vice President, CD Safety, Quality & Environmental Protection, Boehringer-Ingelheim

·                Consequences for counterfeit penetration
·                GMP issues
·                Recall and complaint management
clock

9:50

CROSS BORDER TRADE

Peter Laurence

Peter Laurence, Director, scb consulting

·                Manufacturer’s channel partners – friend or foe?
·                Supply chain security – is the manufacturer in control?
·                Practical considerations in monitoring cross border flows
·                Minimising the impact of cross border flows on the quality of the demand plan
·                Cross border trade – an easy win for sales management?
clock

10:30

Morning Coffee

clock

11:00

THE IMPACT OF STATE AND FEDERAL GOVERNMENTS IN THE U.S.

Kipp Snider

Kipp Snider, Director, Amgen

  • Overview of state and federal government roles
  • State government basics
  • Medicare and Medicaid programs
  • Current public and political environments
  • The importation debate
  • The future and protecting innovation
clock

11:40

PROSPECTS FOR PARALLEL TRADE IN NORTH AMERICA

Neil Palmer

Neil Palmer, Vice President, RTI Health Solutions

·                Overview of parallel trade in North America
·                Status of legislative initiatives to allow importation and re-importation
·                Understanding how parallel trade in North America would differ from Europe
·                Impact of Medicare Part D on North American parallel trade
·                Trends in Canada and US internet pharmacy sales
·                Factors affecting growth and decline in internet pharmacy
·                Outlook and implications for parallel trade in North America
clock

12:20

Networking Lunch

clock

13:50

PATIENTS INGEST PHARMACEUTICAL TABLETS, NOT BOTTLE LABELS

Bruce Dudzik

Bruce Dudzik, Senior Director , Nanoink

·                Protecting and authenticating the package alone does not certify authentic content
·                Counterfeiter, diverters and legitimate wholesalers switch units and repackage pharmaceutical drugs
·                Unit dosage level protection and authentication is necessary to really ensure patients are getting the right medication
·                Unit dosage level encryption with encrypted batch level data will combat illegal diversion
·                Individual tablet encryptions can house data such as where the product was made, when it was made and where it is to be  shipped to
clock

14:30

CHANGING THE BIO-PHARMACEUTICAL DISTRIBUTION MODEL

Rolf Fricker

Rolf Fricker, Senior Executive Advisor, Booz Allen Hamilton

·                Parallel trade as threat to industry and patients alike
·                Development of pan-European wholesalers and impact on pharmaceutical distribution in Europe
·                Direct-to-Pharmacy distribution as a way to increase supply chain visibility and control
·                Implementing DTP models, Lessons learned
·                The global picture and limitations of DTP strategies
clock

15:10

CONCEPT OF A SINGLE MARKET

Jim Furniss

Jim Furniss, Director, Pricing & Reimbursement, Bridgehead International

·                Considering the pharmaceutical markets for individual countries and the EU as a single state
·                How feasible is a single market, EU or global?
·                Why wouldn’t a single market work?
clock

16:20

Chairman’s Closing Remarks followed by Afternoon Tea and Close of Conference

Workshops

How to React to Parallel Trade (PM)

How to React to Parallel Trade (PM)

The Hatton, at etc. venues
13 February 2007
London, United Kingdom

Cross Border Trade & the Pharmaceutical Manufacturer (PM)

Cross Border Trade & the Pharmaceutical Manufacturer (PM)

The Hatton, at etc. venues
16 February 2007
London, United Kingdom

The Hatton, at etc. venues

51/53 Hatton Garden
London EC1N 8HN
United Kingdom

The Hatton, at etc. venues

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

Group Booking

Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.